BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15536205)

  • 21. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
    Miranville A; Herling AW; Biemer-Daub G; Voss MD
    Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferrin and iron induce insulin resistance of glucose transport in adipocytes.
    Green A; Basile R; Rumberger JM
    Metabolism; 2006 Aug; 55(8):1042-5. PubMed ID: 16839839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
    Dokken BB; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.
    Lailerd N; Saengsirisuwan V; Sloniger JA; Toskulkao C; Henriksen EJ
    Metabolism; 2004 Jan; 53(1):101-7. PubMed ID: 14681850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
    Dhalla AK; Santikul M; Chisholm JW; Belardinelli L; Reaven GM
    Diabetes Obes Metab; 2009 Feb; 11(2):95-101. PubMed ID: 18494808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of topiramate and sex hormones on energy balance of male and female rats.
    Richard D; Picard F; Lemieux C; Lalonde J; Samson P; Deshaies Y
    Int J Obes Relat Metab Disord; 2002 Mar; 26(3):344-53. PubMed ID: 11896489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression.
    Ryder JW; Portocarrero CP; Song XM; Cui L; Yu M; Combatsiaris T; Galuska D; Bauman DE; Barbano DM; Charron MJ; Zierath JR; Houseknecht KL
    Diabetes; 2001 May; 50(5):1149-57. PubMed ID: 11334420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a beta3-adrenergic agonist on glucose uptake and leptin expression and secretion in cultured adipocytes from lean and overweight (cafeteria) rats.
    Moreno-Aliaga MJ; Lamas O; Marti A; Martínez JA
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1201-7. PubMed ID: 11883944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance.
    Henriksen EJ; Jacob S; Fogt DL; Dietze GJ
    Am J Physiol; 1998 Jul; 275(1):R40-5. PubMed ID: 9688958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a new hypoglycemic agent A-4166 on glucose metabolism in rat adipocytes and muscle tissues.
    Macho L; Ficková M; Zórad S; Seböková E; Klimes I
    Gen Physiol Biophys; 1999 Sep; 18(3):293-303. PubMed ID: 10703745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles.
    Jessen N; Selmer Buhl E; Pold R; Schmitz O; Lund S
    Horm Metab Res; 2008 Apr; 40(4):269-75. PubMed ID: 18548386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
    Alemzadeh R; Tushaus KM
    Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.
    Reeds DN; Yarasheski KE; Fontana L; Cade WT; Laciny E; DeMoss A; Patterson BW; Powderly WG; Klein S
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E47-E53. PubMed ID: 16118251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat.
    Muellenbach EA; Diehl CJ; Teachey MK; Lindborg KA; Archuleta TL; Harrell NB; Andersen G; Somoza V; Hasselwander O; Matuschek M; Henriksen EJ
    Metabolism; 2008 Oct; 57(10):1465-72. PubMed ID: 18803954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.
    Henriksen EJ; Jacob S; Fogt DL; Youngblood EB; Gödicke J
    Hypertension; 1997 Dec; 30(6):1560-5. PubMed ID: 9403583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.